- Extreme weather events such as typhoon, heavy snow, and rainstorm may cause interruptions in business activities (such as supply chain disruptions, employee shortages) and increase costs (extreme weather causing chemicals and other substances to enter the environment, resulting in environmental pollution incidents).
- Climate change may increase infrastructure costs (such as facility damage) and operating costs (such as insufficient water and electricity supply, rising prices).
- More rigorous carbon emission policies may increase operational costs (such as compliance costs) and lead to the write-off or scrapping of existing assets.
- New technology or product development failure may lead to wastage of R&D expenses for new technologies or products and write-off or scrapping of existing assets.
- Rising material costs and market information uncertainty may increase investment costs and operating costs.
- Industrial stigmatization and stakeholder concerns may reduce available capital and impact on labor management and planning.
JACOBIO PHARMACEUTICALS GROUP CO., LTD.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, JACOBIO PHARMACEUTICALS GROUP CO., LTD. disclosed greenhouse gas emissions of 1.5K tCO2e/year. By scope: Scope 1: 33.98 tCO2e/year; Scope 2: 1.5K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.5K tCO2e/year
2023
Water Usage
5.1K tonnes/year
2023
Waste
57.98 tonnes hazardous waste/year, 8.26 tonnes non-hazardous waste/year
2023
Energy Use
2.8K MWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 33.98 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 1.5K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- All laboratory exhaust gases achieve harmless treatment that is 10% higher than the national emission standard.
- Completed the installation of direct drinking machines in all office and laboratory areas of the new base. A total of 16 direct drinking machines were installed to replace all bottled water.
- Per capita paper consumption has decreased by 74.5% compared to 2022 and 77.8% compared to 2021.
- Installation rate of LED lights in the Beijing new base office and Shanghai office has reached 100%.
- 83.7% of the various instruments and equipment newly purchased by our Company have met or exceeded the national first-class energy efficiency standard.
- 100 percent of the laboratories in the new base in Beijing have been equipped with water-saving equipment.
- 100% procurement of office paper with Chinese environmental label product certification.
🎯 Climate & Sustainability Targets
🔜 Short-term
- By the end of 2024, all office spaces of our Company will pass the ISO 14001 environmental management system certification.
- By the end of 2025, the Company will fully promote paperless office, and the paper per capita will be reduced to 50% compared with 2020.
📅 Medium-term
- By the end of 2025, all unutilized Net Proceeds from the Global Offering will be utilized.
🔭 Long-term
- By the end of 2060, our Company’s operating premises in China will fully achieve carbon neutrality.
🌱 ESG Focus Areas
Corporate GovernanceClinical Trial SafetyProduct Quality SafetyIntellectual Property ProtectionBusiness EthicsR&DAnti-CorruptionOccupational Health and SafetyBasic Rights of EmployeesData Security and Customer Privacy ProtectionSupply Chain ManagementTalent Training and DevelopmentEmission ManagementTalent Attraction and RetentionEmployee DiversityResource ManagementGreenhouse Gas EmissionsMedical AccessibilityAddressing Climate ChangeCommunity InvestmentDriving Industry Development